An enabling environment
HSBI is propelled by pugnacity, convictions, but also by its own energy and own funds.
The institutional and social context of fight against IAS, the biotechnological progress and the involvement of various pharmaceutical industry and healthcare actors are conducive to a sustainable development and the rise of the industrial process.
As in all projects with variable structure, new partners would help us to increase our visibility in the pharmaceutical industry field, to strengthen our technical-economic and commercial strategy and to open up European and international horizons.
Join our biotech support to fight nosocomial risks.